These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Characteristics, management, and outcome of pediatric patients with post-transplant lymphoproliferative disease-A 20 years' experience from Austria. Füreder A, Kropshofer G, Benesch M, Dworzak M, Greil S, Huber WD, Hubmann H, Lawitschka A, Mann G, Michel-Behnke I, Müller-Sacherer T, Pichler H, Simonitsch-Klupp I, Schwinger W, Szepfalusi Z, Crazzolara R, Attarbaschi A, Austrian Society of Pediatric Hematology and Oncology. Cancer Rep (Hoboken); 2021 Oct; 4(5):e1375. PubMed ID: 33755341 [Abstract] [Full Text] [Related]
19. Cytogenetic analysis of B-cell posttransplant lymphoproliferations validates the World Health Organization classification and suggests inclusion of florid follicular hyperplasia as a precursor lesion. Vakiani E, Nandula SV, Subramaniyam S, Keller CE, Alobeid B, Murty VV, Bhagat G. Hum Pathol; 2007 Feb; 38(2):315-25. PubMed ID: 17134734 [Abstract] [Full Text] [Related]
20. Expression of intratumoral forkhead box protein 3 in posttransplant lymphoproliferative disorders: clinical features and survival outcomes. Berglund D, Kinch A, Edman E, Backlin C, Enblad G, Larsson E, Molin D, Pauksens K, Sundström C, Baecklund E. Transplantation; 2015 May; 99(5):1036-42. PubMed ID: 25211518 [Abstract] [Full Text] [Related] Page: [Next] [New Search]